|
US5847172A
(en)
*
|
1995-06-07 |
1998-12-08 |
Magainin Pharmaceuticals Inc. |
Certain aminosterol compounds and pharmaceutical compositions including these compounds
|
|
WO2000009137A2
(en)
*
|
1998-08-12 |
2000-02-24 |
Magainin Pharmaceuticals, Inc. |
Aminosterol compounds and uses thereof
|
|
AU757649B2
(en)
*
|
1998-09-10 |
2003-02-27 |
Genaera Corporation |
Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
|
|
EP1156823B1
(en)
*
|
1999-02-12 |
2008-10-29 |
The Scripps Research Institute |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
|
|
US7820718B1
(en)
|
1999-04-07 |
2010-10-26 |
Roger Williams Hospital |
Combinations of ceramide and chemotherapeutic agents for inducing cell death and uses thereof in treating cancer
|
|
CA2413313C
(en)
|
2000-06-23 |
2011-06-14 |
Mitsubishi Pharma Corporation |
Antitumor effect potentiators
|
|
US20020073441A1
(en)
|
2000-12-13 |
2002-06-13 |
Ross Brian D. |
Compositions and methods for detecting proteolytic activity
|
|
CA2456746A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Method for treating lung cancers
|
|
CA2457148A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
GB0126879D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Astrazeneca Ab |
Combination therapy
|
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
US9186322B2
(en)
*
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
CN1681478A
(zh)
*
|
2002-08-02 |
2005-10-12 |
川塞夫有限公司 |
铂聚集体及其制备方法
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
KR101301653B1
(ko)
*
|
2002-10-29 |
2013-08-30 |
트랜세이브, 인코포레이티드 |
항감염제의 지속적인 방출
|
|
US7718189B2
(en)
*
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US20080194019A1
(en)
*
|
2003-09-09 |
2008-08-14 |
Beth Israel Deaconess Medical Center, Inc. |
Tumor Suppressor Lkb1 Kinase Directly Activates Amp-Activated Kinase
|
|
US20070053845A1
(en)
*
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
AU2005219413A1
(en)
*
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
AU2005223654A1
(en)
*
|
2004-03-18 |
2005-09-29 |
Transave, Inc. |
Administration of cisplatin by inhalation
|
|
US20060034906A1
(en)
*
|
2004-05-21 |
2006-02-16 |
Transave, Inc. |
Treatment of lung diseases and pre-lung disease conditions
|
|
JP2008514726A
(ja)
*
|
2004-09-30 |
2008-05-08 |
ザ ユニヴァーシティー オヴ シカゴ |
ヘッジホッグ阻害剤、放射線及び化学療法薬の併用療法
|
|
EP1811963A4
(en)
*
|
2004-11-08 |
2010-01-06 |
Transave Inc |
METHOD FOR CREATING TREATMENT WITH INTRAPERITONEALLY APPLIED PLATINUM COMPOUND FORMULATIONS ON LIPID BASIS
|
|
US20090110633A1
(en)
*
|
2005-03-14 |
2009-04-30 |
Shiladitya Sengupta |
Nanocells for Diagnosis and Treatment of Diseases and Disorders
|
|
TW200716136A
(en)
|
2005-04-25 |
2007-05-01 |
Genaera Corp |
Polymorphic and amorphous salt forms of squalamine dilactate
|
|
WO2006119211A2
(en)
*
|
2005-05-02 |
2006-11-09 |
Genaera Corporation |
Methods and compositions for treating ocular disorders
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
WO2007056263A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
WO2007056236A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
|
|
WO2007056264A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
WO2007064658A2
(en)
*
|
2005-11-30 |
2007-06-07 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
JP5324223B2
(ja)
|
2005-12-08 |
2013-10-23 |
トランセイブ， インク． |
肺感染症を治療する抗感染薬の脂質ベースの組成物及びその使用法
|
|
WO2008112987A1
(en)
*
|
2007-03-14 |
2008-09-18 |
Mayo Foundation For Medical Education And Research |
Treating skin cancer
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9611313B2
(en)
*
|
2007-06-26 |
2017-04-04 |
University Of Miami |
Antibody-endostatin fusion protein and its variants
|
|
RU2365370C1
(ru)
*
|
2008-04-29 |
2009-08-27 |
Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
RU2367436C1
(ru)
*
|
2008-05-26 |
2009-09-20 |
Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
WO2010003057A2
(en)
|
2008-07-03 |
2010-01-07 |
Mayo Foundation For Medical Education And Research |
Treating cancer
|
|
RU2388503C1
(ru)
*
|
2008-08-14 |
2010-05-10 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ лечения рака легкого
|
|
RU2402280C2
(ru)
*
|
2008-12-01 |
2010-10-27 |
Федеральное государственное учреждение "Российский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ прогнозирования церебральных метастазов рака легкого
|
|
RU2406452C1
(ru)
*
|
2009-06-22 |
2010-12-20 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ лечения рака легкого
|
|
RU2414894C1
(ru)
*
|
2009-06-29 |
2011-03-27 |
Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
WO2011056650A2
(en)
*
|
2009-10-27 |
2011-05-12 |
Michael Zasloff |
Methods and compositions for treating and preventing viral infections
|
|
US8623416B2
(en)
*
|
2009-11-25 |
2014-01-07 |
Michael Zasloff |
Formulations comprising aminosterols
|
|
RU2411018C1
(ru)
*
|
2009-12-22 |
2011-02-10 |
Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" |
Способ локальной химиотерапии метастазов в печень
|
|
RU2429842C1
(ru)
*
|
2010-06-15 |
2011-09-27 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ профилактики послеоперационных осложнений при комбинированном лечении больных немелкоклеточным раком легкого iii стадии
|
|
HRP20200793T1
(hr)
|
2011-05-09 |
2020-10-16 |
Mayo Foundation For Medical Education And Research |
Liječenje raka
|
|
DK2831110T3
(en)
*
|
2012-03-30 |
2018-08-06 |
Univ California |
Anti-EMP2 therapy to reduce cancer stem cells
|
|
WO2013155346A1
(en)
|
2012-04-11 |
2013-10-17 |
The Regents Of The University Of California |
Diagnostic tools for response to 6-thiopurine therapy
|
|
PL2852391T3
(pl)
|
2012-05-21 |
2022-04-11 |
Insmed Incorporated |
Układy do leczenia infekcji płuc
|
|
PL2892524T3
(pl)
|
2012-09-04 |
2021-10-25 |
Eleison Pharmaceuticals, Llc |
Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
|
|
CA2917407C
(en)
|
2012-10-01 |
2023-03-14 |
Mayo Foundation For Medical Education And Research |
Complexes containing albumin-containing nanoparticles and antibodies to treat cancer
|
|
MX2015006681A
(es)
|
2012-11-29 |
2016-04-06 |
Insmed Inc |
Formulaciones de vancomicina estabilizadas.
|
|
US10040817B2
(en)
|
2013-10-03 |
2018-08-07 |
Enterin Laboratories, Inc. |
Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
|
|
SMT202000516T1
(it)
|
2014-05-15 |
2020-11-10 |
Insmed Inc |
Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
|
|
CA2950926A1
(en)
|
2014-06-13 |
2015-12-17 |
Mayo Foundation For Medical Education And Research |
Albumin-bound paclitaxel nanoparticle/rituximab complexes for treatment of cd20-expressing lymphomas
|
|
JP6600651B2
(ja)
|
2014-06-16 |
2019-10-30 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
骨髄腫の治療
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
EP3399861A4
(en)
|
2016-01-07 |
2019-08-07 |
Mayo Foundation for Medical Education and Research |
METHOD FOR THE TREATMENT OF CANCER WITH INTERFERON
|
|
US11351254B2
(en)
|
2016-02-12 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
EP3432926A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
METHOD FOR REDUCING THE TOXICITY OF CHEMOTHERAPEUTICS
|
|
CA3018340A1
(en)
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for improving the therapeutic index for a chemotherapeutic drug
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
EP3506950A1
(en)
|
2016-09-01 |
2019-07-10 |
Mayo Foundation for Medical Education and Research |
Methods and compositions for targeting t-cell cancers
|
|
JP7525999B2
(ja)
|
2016-09-01 |
2024-07-31 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
キャリアー－ｐｄ－ｌ１結合剤組成物及び癌を処置する為にそれを使用する方法
|
|
RU2756892C2
(ru)
|
2016-09-06 |
2021-10-06 |
Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч |
Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения
|
|
CN109843924A
(zh)
|
2016-09-06 |
2019-06-04 |
梅约医学教育与研究基金会 |
治疗表达pd-l1的癌症的方法
|
|
EP3509635A1
(en)
|
2016-09-06 |
2019-07-17 |
Vavotar Life Sciences LLC |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
US11083735B2
(en)
|
2017-09-08 |
2021-08-10 |
Enterin, Inc. |
Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions
|
|
US11674950B2
(en)
*
|
2017-10-31 |
2023-06-13 |
Dana-Farber Cancer Institute, Inc. |
Methods determining and treating cellular resistance to ADP-rtbosylating toxin
|
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
WO2019213398A1
(en)
|
2018-05-02 |
2019-11-07 |
Insmed Incorporated |
Methods for the manufacture of liposomal drug formulations
|
|
CN116407640B
(zh)
*
|
2023-03-03 |
2025-10-31 |
河南真实生物科技有限公司 |
包含阿兹夫定和化疗试剂的抗肿瘤药物组合物
|